Cargando…
MDS and TP53: When One Hit Just Isn’t Enough…
Autor principal: | Kent, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655086/ https://www.ncbi.nlm.nih.gov/pubmed/33196012 http://dx.doi.org/10.1097/HS9.0000000000000494 |
Ejemplares similares
-
Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023) -
Just a Spoonful of Sugar Helps the HSCs Move ’Round
por: Kent, David G.
Publicado: (2021) -
The Next Generation of FACS – Not Just a Uniform Blob of Fluorescence
por: Kent, David G.
Publicado: (2022) -
When Alarmins Are “Therapeutic”
por: Vinchi, Francesca
Publicado: (2020) -
There and Back Again: A Cytokine Receptor's Tail
por: Kent, David
Publicado: (2020)